Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Climb Bio, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +26 vs. Q1 2024
- Shares held
- 49.9M
- +33.1M (+196.1%) vs. Q1 2024
- Total value
- $354.8M
- +$308.6M (+668.1%) vs. Q1 2024
- New holders
- 31
- 10 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLYM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $734.3M |
| Q1 2026 | 80 | $221.2M |
| Q4 2025 | 65 | $157.4M |
| Q3 2025 | 68 | $89.7M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 80 | $100.3M |
| Q3 2024 | 71 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 21 | $46.2M |
| Q4 2023 | 23 | $45.5M |
| Q3 2023 | 23 | $44.0M |
| Q2 2023 | 22 | $46.8M |
| Q1 2023 | 19 | $48.4M |
| Q4 2022 | 20 | $61.0M |
| Q3 2022 | 22 | $47.8M |
| Q2 2022 | 29 | $45.7M |
| Q1 2022 | 43 | $146.8M |
| Q4 2021 | 35 | $181.8M |
| Q3 2021 | 32 | $310.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Climb Bio, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 252 | $2.00K | 0.00% | +252 | New |
| California State Teachers Retirement System | 528 | $3.75K | 0.00% | +528 | New |
| Legal & General Group Plc | 631 | $4.52K | 0.00% | +631 | New |
| Royal Bank of Canada | 686 | $5.00K | 0.00% | +623+988.9% | Added |
| Ameritas Investment Partners, Inc. | 714 | $5.08K | 0.00% | +714 | New |
| Citigroup Inc | 1,632 | $11.6K | 0.00% | +1,632 | New |
| UBS Group AG | 2,218 | $15.8K | 0.00% | −3,707−62.6% | Reduced |
| Barclays PLC | 2,543 | $18.1K | 0.00% | +2,543 | New |
| Tower Research Capital LLC (TRC) | 3,020 | $21.5K | 0.00% | −586−16.3% | Reduced |
| Advisor Group Holdings, Inc. | 8,333 | $21.7K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,104 | $22.1K | 0.00% | +3,104 | New |
| Wells Fargo & Company | 3,149 | $22.4K | 0.00% | +3,099+6,198.0% | Added |
| Corebridge Financial, Inc. | 3,918 | $27.9K | 0.00% | +3,918 | New |
| STRS Ohio | 5,300 | $37.7K | 0.00% | +5,300 | New |
| Rhumbline Advisers | 8,233 | $58.5K | 0.00% | +8,233 | New |
| Bank of America Corp | 9,247 | $65.7K | 0.00% | +9,247 | New |
| Morgan Stanley | 9,883 | $70.3K | 0.00% | +8,174+478.3% | Added |
| Two Sigma Securities, LLC | 10,619 | $75.5K | 0.00% | +10,619 | New |
| Polar Asset Management Partners Inc. | 10,781 | $76.7K | 0.00% | +10,781 | New |
| Millennium Management LLC | 11,397 | $81.0K | 0.00% | −8,709−43.3% | Reduced |
| Dimensional Fund Advisors LP | 12,560 | $89.3K | 0.00% | +12,560 | New |
| New York State Common Retirement Fund | 13,300 | $94.6K | 0.00% | +13,300 | New |
| Charles Schwab Investment Management Inc | 17,128 | $121.8K | 0.00% | +17,128 | New |
| Bank of New York Mellon Corp | 18,845 | $134.0K | 0.00% | +18,845 | New |
| Woodline Partners LP | 22,192 | $157.8K | 0.00% | +22,192 | New |
| Boothbay Fund Management, LLC | 30,710 | $218.3K | 0.01% | +30,710 | New |
| Man Group plc | 33,567 | $238.7K | 0.00% | +33,567 | New |
| Renaissance Technologies LLC | 37,000 | $263.1K | 0.00% | +26,383+248.5% | Added |
| Northern Trust Corp | 45,677 | $324.8K | 0.00% | +2,209+5.1% | Added |
| Bridgeway Capital Management, LLC | 55,223 | $392.6K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 59,007 | $419.5K | 0.00% | +37,307+171.9% | Added |
| ADAR1 Capital Management, LLC | 97,695 | $694.6K | 0.14% | +97,695 | New |
| Ikarian Capital, LLC | 100,000 | $711.0K | 0.22% | +100,000 | New |
| Geode Capital Management, LLC | 171,597 | $1.22M | 0.00% | +104,971+157.6% | Added |
| Walleye Capital LLC | 196,390 | $1.40M | 0.01% | +196,390 | New |
| Sphera Funds Management Ltd. | 215,179 | $1.53M | 0.25% | +215,179 | New |
| Vanguard Group Inc | 326,381 | $2.32M | 0.00% | +15,895+5.1% | Added |
| BlackRock Inc. | 381,723 | $2.71M | 0.00% | +351,283+1,154.0% | Added |
| Ally Bridge Group (NY) LLC | 500,000 | $3.56M | 2.12% | +500,000 | New |
| Adage Capital Partners GP, L.L.C. | 670,362 | $4.77M | 0.01% | +670,362 | New |
| Driehaus Capital Management LLC | 696,057 | $4.95M | 0.05% | −115,623−14.2% | Reduced |
| Affinity Asset Advisors, LLC | 1,670,661 | $11.9M | 1.87% | +1,670,661 | New |
| Boxer Capital, LLC | 2,603,190 | $18.5M | 0.97% | +2,603,190 | New |
| Janus Henderson Group PLC | 3,253,988 | $23.1M | 0.01% | +3,253,988 | New |
| Samsara BioCapital, LLC | 3,261,393 | $23.2M | 4.85% | +3,261,393 | New |
| Deep Track Capital, LP | 3,904,785 | $27.8M | 0.83% | +3,904,785 | New |
| Ra Capital Management, L.P. | 31,419,267 | $223.4M | 2.95% | +18,268,418+138.9% | Added |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −2,193,742−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −78,276−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −29,466−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −12,104−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −981−100.0% | Sold out |